Related Experiment Video

Updated: Aug 15, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Effect of statins in stroke prevention

Pierre Amarenco1

  • 1Department of Neurology and Stroke Centre, Bichat University Hospital, Denis Diderot University and Medical School, Paris, France. amarenco@ccr.jussieu.fr

Current Opinion in Lipidology
|November 9, 2005
PubMed

Insights

Statin therapy shows promise in preventing major coronary events after a stroke. However, current evidence does not yet confirm its effectiveness in preventing recurrent strokes, despite lowering LDL cholesterol.

Area of Science:

  • Neurology
  • Cardiology
  • Pharmacology

Background:

  • Epidemiological studies show limited association between cholesterol and stroke.
  • Randomized trials demonstrate LDL lowering reduces stroke risk in various patient groups.
  • Meta-analyses indicate a dose-response relationship between LDL reduction and decreased stroke incidence.

Purpose of the Study:

  • To review clinical trial outcomes of statin therapy for stroke prevention and treatment.
  • To evaluate the efficacy of statins in reducing stroke risk and recurrence.

Main Methods:

  • Review of recent clinical trials on statin use in stroke.
  • Analysis of data from large-scale trials like the Heart Protection Study and SPARCL.
  • Examination of LDL cholesterol reduction as a primary mechanism of action.

Main Results:

  • Statin therapy, primarily through LDL reduction, positively impacts stroke outcomes in coronary heart disease patients.
  • Significant stroke risk reduction observed in diabetic, hypertensive, and CAD patients with statin use.
  • The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial aims to provide definitive answers on statin efficacy.

Conclusions:

  • Statin's benefit in stroke prevention is largely attributed to LDL reduction, with potential pleiotropic effects.
  • Statins are effective in preventing major coronary events post-stroke.
  • Evidence for statins preventing recurrent stroke remains inconclusive.
Abstract

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...